Reliq Health Technologies Inc.
RQHTF
$0.0001
-$0.0099-99.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 107.91% | 159.51% | 257.97% | 488.60% | 537.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 107.91% | 159.51% | 257.97% | 488.60% | 537.75% |
| Cost of Revenue | 184.36% | 277.60% | 328.87% | 439.52% | 154.81% |
| Gross Profit | 76.79% | 112.83% | 223.34% | 523.27% | 1,542.53% |
| SG&A Expenses | -42.98% | -52.64% | -41.83% | 8.29% | 17.91% |
| Depreciation & Amortization | -37.35% | -30.05% | -30.96% | -30.62% | 1,222.31% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.93% | -7.06% | -7.09% | 30.90% | 33.86% |
| Operating Income | 85.42% | 76.13% | 64.62% | 27.55% | 15.04% |
| Income Before Tax | 94.87% | 82.76% | 69.67% | 29.43% | 12.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 94.87% | 82.76% | 69.67% | 29.43% | 12.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 94.87% | 82.76% | 69.67% | 29.43% | 12.83% |
| EBIT | 85.42% | 76.13% | 64.62% | 27.55% | 15.04% |
| EBITDA | 86.12% | 76.59% | 65.07% | 27.20% | 15.00% |
| EPS Basic | 94.51% | 83.27% | 72.49% | 38.64% | 27.13% |
| Normalized Basic EPS | 94.25% | 83.38% | 72.84% | 39.02% | 27.90% |
| EPS Diluted | 94.51% | 83.27% | 72.49% | 38.64% | 27.13% |
| Normalized Diluted EPS | 94.25% | 83.38% | 72.84% | 39.02% | 27.90% |
| Average Basic Shares Outstanding | 2.63% | 6.49% | 10.19% | 14.02% | 20.50% |
| Average Diluted Shares Outstanding | 2.63% | 6.49% | 10.19% | 14.02% | 20.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
